DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay

被引:21
作者
Azqueta, A
Pachón, G
Cascante, M
Creppy, EE
de Cerain, AL
机构
[1] Univ Navarra, CIFA, Pamplona 31008, Spain
[2] Univ Barcelona, Fac Chem, Dept Biochem & Mol Biol, Barcelona 08028, Spain
[3] Univ Bordeaux 2, Dept Toxicol & Appl Hyg, F-33076 Bordeaux, France
关键词
D O I
10.1093/mutage/gei023
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The DNA damage induced by 7-chloro-3-[[(N,N-dimethyl-amino)propyl]amino]-2-quinoxalinecarbonitrile 1,4-di-N-oxide hydrochloride (Q-85 HCl) in Caco-2 cells under hypoxic and well-oxygenated conditions has been studied by using the comet assay. This compound has shown a good in vitro profile of high selective toxicity in hypoxia, but its mechanism of action is unknown. The DNA damage has been evaluated by performing the comet assay after a 2-h treatment with Q-85 HCl (0.1, 0.2, 0.4 mu M in hypoxia; 20, 40 mM in well-oxygenated conditions). The number of cells in apoptosis has also been assessed by flow cytometry analysis of Annexin V-FITC staining. The capability of the cells to repair the DNA damage and the proliferation rate was evaluated at different times after the treatment (24-168 h). Under hypoxic conditions, a clear dose-dependent increase in the number of nuclei with a comet was observed ( comet score: 132 +/- 13, 343 +/- 30 and 399 +/- 1; control comet score: 42 +/- 14). Under well-oxygenated conditions, the number of nuclei with comet increased significantly with respect to the control (comet score: 273 +/- 14, and 312 +/- 9; control comet score: 27 +/- 4). Cells in apoptosis were not detected by the comet assay nor by flow cytometry. The recovery from DNA damage was time-and concentration-dependent in hypoxia (cells treated with the highest concentration still showed DNA damage after 72 h) and rather time-dependent in well-oxygenated conditions ( DNA was completely repaired after 24 h). In conclusion, Q-85 HCl acts by DNA damage and not only the reduced intermediate is genotoxic but also some other derivatives and Q-85 HCl itself may be acting.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 47 条
[1]  
AZQUETA A, 2004, ARZNEIM FORSCH DRUG, V3, P177
[2]   SR-4233 CYTOTOXICITY AND METABOLISM IN DNA REPAIR-COMPETENT AND REPAIR-DEFICIENT CELL-CULTURES [J].
BIEDERMANN, KA ;
WANG, J ;
GRAHAM, RP ;
BROWN, JM .
BRITISH JOURNAL OF CANCER, 1991, 63 (03) :358-362
[3]   Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome [J].
Brizel, DM ;
Dodge, RK ;
Clough, RW ;
Dewhirst, MW .
RADIOTHERAPY AND ONCOLOGY, 1999, 53 (02) :113-117
[4]  
Brown JM, 1999, CANCER RES, V59, P5863
[5]   Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies [J].
Brown, JM .
MOLECULAR MEDICINE TODAY, 2000, 6 (04) :157-162
[6]   THERAPEUTIC ADVANTAGE OF HYPOXIC CELLS IN TUMORS - A THEORETICAL-STUDY [J].
BROWN, JM ;
KOONG, A .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (03) :178-185
[7]  
Brown JM, 1998, CANCER RES, V58, P1408
[8]   THE KINETICS OF REPAIR OF OXIDATIVE DNA-DAMAGE (STRAND BREAKS AND OXIDIZED PYRIMIDINES) IN HUMAN-CELLS [J].
COLLINS, AR ;
MA, AG ;
DUTHIE, SJ .
MUTATION RESEARCH-DNA REPAIR, 1995, 336 (01) :69-77
[9]   Direct evidence for bimodal DNA damage induced by tirapazamine [J].
Daniels, JS ;
Gates, KS ;
Tronche, C ;
Greenberg, MM .
CHEMICAL RESEARCH IN TOXICOLOGY, 1998, 11 (11) :1254-1257
[10]   Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting [J].
Delahoussaye, YM ;
Hay, MP ;
Pruijn, FB ;
Denny, WA ;
Brown, JM .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (11) :1807-1815